Cargando…
The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study
BACKGROUND: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. METHOD: A medication review was conducted in 2015 using version 2...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558549/ https://www.ncbi.nlm.nih.gov/pubmed/31217947 http://dx.doi.org/10.1177/2042098619855535 |
_version_ | 1783425649934860288 |
---|---|
author | Gaubert-Dahan, Marie-Line Sebouai, Abdellatif Tourid, Wafaa Fauvelle, Francis Aikpa, Raoul Bonnet-Zamponi, Dominique |
author_facet | Gaubert-Dahan, Marie-Line Sebouai, Abdellatif Tourid, Wafaa Fauvelle, Francis Aikpa, Raoul Bonnet-Zamponi, Dominique |
author_sort | Gaubert-Dahan, Marie-Line |
collection | PubMed |
description | BACKGROUND: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. METHOD: A medication review was conducted in 2015 using version 2 STOPP and START criteria. The number and type of drugs meeting a STOPP that were reintroduced and the number and type of drug meeting a START that were stopped during follow up were measured. An expert committee adjudicated whether 3-month hospitalizations and deaths were related to medication review. The impact of medication review on the cost related to drug consumption was calculated for 3 months. RESULTS: The 52 residents (age 84 ± 9 years, 83% female) fulfilled, on average, 2 ± 1.4 of the STOPP criteria and 0.7 ± 0.6 of the START criteria. A total of 101 drugs were stopped and 34 drugs were started. Five deaths occurred during follow up and were judged as not related to medication review. Five drugs stopped were reintroduced in five residents for a rebound effect or a symptom occurrence and one resident had stopped a START medication (aspirin) for a minor adverse drug reaction. At 3 months, a gain of 20.21 ± 31.34 euros per resident was observed. CONCLUSION: The medication review using version 2 STOPP and START criteria and involving the physician in charge seems useful for detecting and correcting inappropriate prescribing in a nursing home. |
format | Online Article Text |
id | pubmed-6558549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65585492019-06-19 The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study Gaubert-Dahan, Marie-Line Sebouai, Abdellatif Tourid, Wafaa Fauvelle, Francis Aikpa, Raoul Bonnet-Zamponi, Dominique Ther Adv Drug Saf The role of de-prescribing in polypharmacy and inappropriate medication use BACKGROUND: Improving medication appropriateness is a priority of French national campaigns in nursing homes. A pilot study was conducted to evaluate the impact of a medication review in a French nursing home with a 3-month follow up. METHOD: A medication review was conducted in 2015 using version 2 STOPP and START criteria. The number and type of drugs meeting a STOPP that were reintroduced and the number and type of drug meeting a START that were stopped during follow up were measured. An expert committee adjudicated whether 3-month hospitalizations and deaths were related to medication review. The impact of medication review on the cost related to drug consumption was calculated for 3 months. RESULTS: The 52 residents (age 84 ± 9 years, 83% female) fulfilled, on average, 2 ± 1.4 of the STOPP criteria and 0.7 ± 0.6 of the START criteria. A total of 101 drugs were stopped and 34 drugs were started. Five deaths occurred during follow up and were judged as not related to medication review. Five drugs stopped were reintroduced in five residents for a rebound effect or a symptom occurrence and one resident had stopped a START medication (aspirin) for a minor adverse drug reaction. At 3 months, a gain of 20.21 ± 31.34 euros per resident was observed. CONCLUSION: The medication review using version 2 STOPP and START criteria and involving the physician in charge seems useful for detecting and correcting inappropriate prescribing in a nursing home. SAGE Publications 2019-06-09 /pmc/articles/PMC6558549/ /pubmed/31217947 http://dx.doi.org/10.1177/2042098619855535 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | The role of de-prescribing in polypharmacy and inappropriate medication use Gaubert-Dahan, Marie-Line Sebouai, Abdellatif Tourid, Wafaa Fauvelle, Francis Aikpa, Raoul Bonnet-Zamponi, Dominique The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study |
title | The impact of medication review with version 2 STOPP (Screening Tool
of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to
Right Treatment) criteria in a French nursing home: a 3-month follow-up
study |
title_full | The impact of medication review with version 2 STOPP (Screening Tool
of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to
Right Treatment) criteria in a French nursing home: a 3-month follow-up
study |
title_fullStr | The impact of medication review with version 2 STOPP (Screening Tool
of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to
Right Treatment) criteria in a French nursing home: a 3-month follow-up
study |
title_full_unstemmed | The impact of medication review with version 2 STOPP (Screening Tool
of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to
Right Treatment) criteria in a French nursing home: a 3-month follow-up
study |
title_short | The impact of medication review with version 2 STOPP (Screening Tool
of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to
Right Treatment) criteria in a French nursing home: a 3-month follow-up
study |
title_sort | impact of medication review with version 2 stopp (screening tool
of older person’s prescriptions) and start (screening tool to alert doctors to
right treatment) criteria in a french nursing home: a 3-month follow-up
study |
topic | The role of de-prescribing in polypharmacy and inappropriate medication use |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558549/ https://www.ncbi.nlm.nih.gov/pubmed/31217947 http://dx.doi.org/10.1177/2042098619855535 |
work_keys_str_mv | AT gaubertdahanmarieline theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT sebouaiabdellatif theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT touridwafaa theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT fauvellefrancis theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT aikparaoul theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT bonnetzamponidominique theimpactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT gaubertdahanmarieline impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT sebouaiabdellatif impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT touridwafaa impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT fauvellefrancis impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT aikparaoul impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy AT bonnetzamponidominique impactofmedicationreviewwithversion2stoppscreeningtoolofolderpersonsprescriptionsandstartscreeningtooltoalertdoctorstorighttreatmentcriteriainafrenchnursinghomea3monthfollowupstudy |